Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
UNITAR Appoints Anastasios Economou, YPO Global Chairman and Founder of iGroup, to Advisory Board of the Division for Multilateral Diplomacy
2022-03-30 16:00
New home ownership concept in Thailand's largest property development project combines home with provision of a lifetime of first-class healthcare and wellness services
2022-03-30 15:22
Terumo and Glooko Announce Collaboration on New Solution for Diabetes Data Sharing
2022-03-30 15:00
GILEAD ANNOUNCES NEW DATA REINFORCING CLINICAL BENEFITS OF ITS ANTIVIRAL TREATMENTS AMONG PEOPLE LIVING WITH HEPATITIS B AND C IN ASIA (APASL 2022)
2022-03-30 11:00
First Year of Commercialization, Alphamab Oncology Reports Full Year 2021 Financial Results and Business Highlights
2022-03-30 10:36
Qiming's Portfolio Company Rendu Biotechnology Lists on STAR Market
2022-03-30 10:22
Antengene Announces IND Approval in China for a Phase II Study of Eltanexor (ATG-016) in Patients with High-Risk Myelodysplastic Syndromes
2022-03-30 09:00
RNAimmune Secures $27 Million Series A Round of Financing for Development of mRNA Therapeutics and Vaccines
2022-03-30 08:31
Brii Bio Announces Strategic Partnership with Sinopharm to Advance Commercialization of Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China
2022-03-30 08:05
Everest Medicines Announces that Licensing Partner Pfizer Reports Positive Topline Results from Yearlong Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients, Underscoring Best-in-Class Potential
2022-03-30 08:00
Innovent Announced 2021 Annual Results
2022-03-30 08:00
Telix Granted FDA Orphan Drug Designation for Bone Marrow Conditioning Treatment
2022-03-29 13:34
Daewoong Pharmaceutical submitted NDA for its global new drug Fexuclue Tablets to the Philippines
2022-03-29 09:00
Innovent Announces First Patient Dosing of Claudin18.2/CD3 Bispecific Antibody IBI389 in Phase 1a/1b Clinical Trial for Advanced Solid Tumor
2022-03-29 08:10
Telix and Xiel Sign U.K. and Ireland Distribution Agreement for Illuccix®
2022-03-29 07:39
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2021
2022-03-29 06:30
ILC Dover Announces Liquid Single-Use Bioprocessing Bags for Rapidly Growing Biotherapeutics and Cell & Gene Therapy Markets
2022-03-29 05:11
Viva Biotech Announced 2021 Annual Results: Revenue Increased by 201.9% YoY, CRO Business Revenue Maintained Rapid Growth with an Increase of 68.7%
2022-03-29 01:01
Biocytogen Expands Global Footprint with the Opening of Biocytogen Europe Innovation Center in Germany
2022-03-28 21:30
Vela Diagnostics Launches Focused (60 Genes) and Comprehensive (525 Genes) NGS-Based Pan-Cancer Panels
2022-03-28 15:00
1
258
259
260
261
262
780